Journalists

Journalists

Covering current events in science, the environment, technology and health requires a context and reliable sources that respond quickly.

¿Qué me ofrece?

When science hits the headlines, we publish reactions, explanations, and in-depth analysis from reliable sources, capturing both the evidence and the debates. Our library of science journalism resources and the briefings may be of use to you. Consult our directory of research centres.

Icono
Cómo trabajamos

We are on the lookout for any controversial information about science (embargoed or not), in order to react with the agility the media needs. Sign up to receive our embargoed contents, all under the Creative Commons licence. Find out more about how we work here.

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Use of drugs such as Ozempic is not associated with an increased risk of suicide

The use of GLP-1 analog diabetes drugs-such as semaglutide, sold under the trade name Ozempic-is not linked to an increased risk of suicide, according to two studies published in JAMA Internal Medicine. The first, led by a U.S. team, analyzes data from more than 3,300 people who have participated in clinical trials. The second analyzes data from 124,517 users of these drugs in Sweden and Denmark, and compares them with an even larger group of people who used another type of diabetes medication.

0

Exposure to radiofrequency fields from mobile phone use is not associated with an increased risk of cancer

The radiation exposure from mobile phone use does not increase the risk of brain cancer, with evidence of “moderate” certainty, according to a systematic review, funded in part by the WHO and published in Environmental International. Exposure from fixed-site transmitters (like broadcast antennas) is also not associated with childhood leukaemia.

0

CNIC team proposes a new cardiovascular risk factor and a drug to reduce its effects

In a study published in the journal Nature Medicine, a team of researchers from the National Center for Cardiovascular Research (CNIC) proposes a new cardiovascular risk factor to add to those already known. It is clonal hematopoiesis, a phenomenon caused by acquired mutations in blood stem cells. Furthermore, in a separate study published in the European Heart Journal, they suggest that the drug colchicine could serve to reduce its effects.

0

A review analyzes the environmental effects of genetically modified crops

An international team of researchers publishes a review of the complex environmental impacts of genetically modified crops in the journal Science. According to the study, widespread adoption by some of the world's largest agricultural countries has had mixed results for biodiversity, deforestation and human health, depending on the specific characteristics of these crops and the regions involved. 

0

Metagenome sequencing of bacteria, fungi, and yeasts present in more than 2,500 foods

An international team with Spanish participation has developed a database with the metagenome of bacteria, fungi, and yeasts present in more than 2,500 foods, mostly dairy products, followed by beverages and fermented meats. The authors identified more than 10,800 microorganisms, half of which were previously unknown species. The study, published in Cell, shows that food-associated microorganisms are present in 3% of the adult gut microbiome and 56% of that of newborns.

0

High-risk Human Papillomavirus (HPV) genotypes linked to reduced male fertility

The sperm of men infected with high-risk genotypes of the human papillomavirus (HPV) suffers more damage from oxidative stress and has a weaker immune response, which can lead to reduced fertility. This is one of the conclusions of a study published in the journal Frontiers in Cellular and Infection Microbiology. The research compared the semen of 20 adults infected with high-risk genotypes, seven infected with low-risk genotypes, and 43 adults without infections.

0